Booth, L., Roberts, J. L., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., Poklepovic, A., & Dent, P. (2018). The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells. Cancer Biol Ther.

Booth, Laurence, Jane L. Roberts, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani, Andrew Poklepovic, i Paul Dent. "The Irreversible ERBB1/2/4 Inhibitor Neratinib Interacts With the BCL-2 Inhibitor Venetoclax to Kill Mammary Cancer Cells." Cancer Biol Ther 2018.

Booth, Laurence, et al. "The Irreversible ERBB1/2/4 Inhibitor Neratinib Interacts With the BCL-2 Inhibitor Venetoclax to Kill Mammary Cancer Cells." Cancer Biol Ther 2018.